Vendor, Morrisville, NC
Locus Biosciences Inc.
UEI CJKVLKZGX6F3, CAGE 7H2T2
1 award and $0 obligated between July 7, 2026 and August 26, 2026, 100% under full and open competition, against 16.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00035Definitive Contract, July 7, 2026, Full and Open Competition, 16 offers | National Institutes of Health NiaidNational Institutes of Health | Eo 14398 Advance a Novel Therapeutic to a First-In-Human Clinical StudyNAICS 541714, PSC AN12 | $0 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards